Aurinia Pharmaceuticals (AUPH) Asset Writedowns and Impairment (2021 - 2022)
Aurinia Pharmaceuticals (AUPH) posted Asset Writedowns and Impairment of $1.2 million for Q4 2022, up 382.45% on a QoQ basis from $245000.0 in Q4 2021, and up 382.45% year-over-year from $245000.0 in Q4 2021.
Aurinia Pharmaceuticals (AUPH) Asset Writedowns and Impairment (2021 - 2022) Analysis & Trends
Aurinia Pharmaceuticals' Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at $1.2 million for Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.18 Mn |
| Dec 31, 2022 | 1.18 Mn |
| Dec 31, 2021 | 245,000.00 |
| Dec 31, 2021 | 245,000.00 |